Hepatic steatosis index for prediction of metabolic dysfunction‐associated steatotic liver disease ( MASLD ) among young Indian women with gestational diabetes and normoglycaemia during index pregnancy

Ejemplares similares

• Implications of antenatal 1‐hour postload plasma glucose (≥ 11.6 mmol/L) for postpartum diabetes and cardiometabolic risk assessment in women with gestational diabetes: Post hoc analysis from the CHIP ‐F study
  por: Yashdeep Gupta, et al.
  Publicado: (2024)
• Pregnancy and postpartum cardiometabolic outcomes among women with overt diabetes compared to women with normoglycaemia, gestational diabetes and pre‐existing diabetes: A systematic review and meta‐analysis
  por: Adarsh Pal, et al.
  Publicado: (2025)
• Comparative efficacy and safety of pharmacologic therapies for metabolic dysfunction‐associated steatotic liver disease over 24 weeks in reducing liver steatosis and fibrosis: A network meta‐analysis
  por: Jiaxin Zhong, et al.
  Publicado: (2025)
• Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease
  por: Federica Tavaglione, et al.
  Publicado: (2024)
• Characterization of brain morphology associated with metabolic dysfunction‐associated steatotic liver disease in the UK Biobank
  por: Wenxiao Fan, et al.
  Publicado: (2025)